VRDN · ISSUER CIK 1590750
Viridian Therapeutics, Inc.\DE
Between Aug 1, 2026 and Oct 29, 2026, 2 Viridian Therapeutics, Inc.\DE insiders reported $0.00 of open-market purchases and $348K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$348KInsider selling
−$348KNet open-market
Aug 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 202620:05 | Aug 19, 2026 | VRDN | Chief Legal Officer | S · Sell | $24.50 | −14,212 | 0 | -100% | −$348K | ||
| Aug 20, 202620:05 | Aug 19, 2026 | VRDN | Chief Legal Officer | M · Exercise | $14.41 | +10,000 | 10,000 | New | $144K | ||
| Aug 18, 202617:34 | Aug 14, 2026 | VRDN | Chief Medical Officer | M · Exercise | $13.21 | +40,000 | 40,000 | New | $528K |